Document Detail


Treating hyperlipidemia, Part III: Drug therapy.
MedLine Citation:
PMID:  3110017     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In elderly patients at increased risk for cardiovascular disease due to lipid abnormalities, numerous medications are available for altering such abnormalities. Most of these drugs have side effects which, in the elderly, may necessitate lower dosing than usual. For persons with severe elevations of triglycerides, nicotinic acid (Niacin) and gemfibrozil (Lopid) may be used. For those who need a reduction in the LDL cholesterol, choices include bile acid-binding resins, nicotinic acid, HMG CoA reductase inhibitors, probucol (Lorelco), and neomycin.
Authors:
D A Smith; W Karmally; W V Brown
Related Documents :
7654887 - Review article: factors protecting the oesophagus against acid-mediated injury.
10956127 - Discriminate analysis of roasted coffee varieties for trigonelline, nicotinic acid, and...
9187887 - The roles of excessive gastro-oesophageal reflux, disordered oesophageal motility and d...
22179247 - Mutation of the nadh oxidase gene (nox) reveals an overlap of the oxygen- and acid-medi...
9603887 - D-alanylcardiolipin, a major component of the unique lipid pattern of vagococcus fluvia...
9017507 - Comparison of side chain oxidation of potential c27-bile acid intermediates between mit...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Geriatrics     Volume:  42     ISSN:  0016-867X     ISO Abbreviation:  Geriatrics     Publication Date:  1987 Aug 
Date Detail:
Created Date:  1987-08-26     Completed Date:  1987-08-26     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  2985102R     Medline TA:  Geriatrics     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  55-9, 62     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Antilipemic Agents / administration & dosage,  therapeutic use*
Enzyme Inhibitors / administration & dosage,  therapeutic use
Gemfibrozil
Heptanoic Acids / administration & dosage,  therapeutic use
Humans
Hypercholesterolemia / drug therapy
Hyperlipidemias / drug therapy*
Naphthalenes / administration & dosage,  therapeutic use
Neomycin / administration & dosage,  therapeutic use
Niacin / administration & dosage,  therapeutic use
Pentanoic Acids / administration & dosage,  therapeutic use
Pravastatin
Chemical
Reg. No./Substance:
0/Antilipemic Agents; 0/Enzyme Inhibitors; 0/Heptanoic Acids; 0/Naphthalenes; 0/Pentanoic Acids; 1404-04-2/Neomycin; 25812-30-0/Gemfibrozil; 59-67-6/Niacin; 81093-37-0/Pravastatin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The aging thyroid in health and disease.
Next Document:  Quantitative triple fluorochrome labeling study of lathyritic-rat mandible.